Evidence map›Paper›PMID 36245625›Full record

ArticleJournal of thoracic disease2022

Structure-based classification of

Tao Wang, Jun Cao, Qi Song, Li Wang, Yuanyuan Xiong, Rongrong Chen

Open access · diamondAbstract read
In one paragraph

Article in Journal of thoracic disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Translational lung cancer research · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Tao Wang *Department of Thoracic Surgery, the First Medical Center of PLA General Hospital, Beijing, China.
Jun Cao *Department of Pathology, Tongxiang First People's Hospital, Tongxiang, China.
Qi Song *Department of Oncology, Affiliated Qingdao Central Hospital, Qingdao University, Qingdao, China.
Li WangGeneplus-Beijing Institute, Beijing, China.
Yuanyuan XiongGeneplus-Beijing Institute, Beijing, China.
Rongrong ChenGeneplus-Beijing Institute, Beijing, China.
Affiliated Hospital of Qingdao University · CNChinese PLA General Hospital · CNYinchuan First People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: It has been reported that the structure-based approach for defining functional groups of epidermal growth factor receptor ( Methods: Non-small cell lung cancer (NSCLC) patients with pathological stage I-III or adenocarcinoma in situ (AIS) who had Results: In total 1,012 patients including 66 AIS and 946 stage I-III patients were analyzed in the study. A total of 1185 Conclusions: This large cross-sectional study delineated the structure-based classification of

Indexed as

Adenocarcinoma in situ (AIS)atypical EGFR mutationsepidermal growth factor receptor (EGFR)non-small cell lung cancer (NSCLC)structure-based classification

Identifiers

PMID36245625
PMCPMC9562547
OpenAlexW4295910789

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.